Mersana Therapeutics, Inc. Long-Term Debt
Mersana Therapeutics, Inc. had Long-Term Debt of $0 as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2025-11-14
- 2025-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2025-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2025-03-31: Long-term Debt, Excluding Current Maturities $7.90M.
- 2024-12-31: Long-term Debt, Excluding Current Maturities $10.95M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $7.90M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $10.95M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $14.00M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $17.05M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $19.79M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $23.15M 10-K · filed 2025-03-03 |
| 2023-09-30 | $25.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $25.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $25.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $24.93M 10-K · filed 2024-02-28 |
| 2022-09-30 | $25.00M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $25.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $25.00M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $24.63M 10-K · filed 2023-02-28 |
| 2021-09-30 | $5.20M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.03M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $5.20M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $4.98M 10-K · filed 2022-02-28 |
| 2020-09-30 | $4.94M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $3.26M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $3.73M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $4.20M 10-K · filed 2021-02-26 |
| 2019-09-30 | $4.67M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $4.80M 10-Q · filed 2019-08-08 |